Insider trade

Nuvectis Pharma (NVCT): 10% owner bought ~$88K

Mosseri Marlio Charles, 10% owner at Nuvectis Pharma, bought ~$88K of Nuvectis Pharma shares.

~$88K
Approx. value · 9,850 sh @ $8.95
2.92M
Holds after · shares reported
Traded
May 9, 2025
Filed
May 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 8, 2025Insider · 1 personInsiders: 3 purchases (~$23K)
  2. May 9, 2025 · this disclosureInsider10% owner purchased ~$88K of NVCT shares in the open market

What came next

  1. May 9, 2025Insider · 1 personInsiders: 2 purchases (~$136K)
  2. May 12, 2025Insider10% owner purchased ~$172K of NVCT shares in the open market
  3. Jun 17, 2025Insider10% owner purchased ~$44K of NVCT shares in the open market
  4. Jun 18, 2025Insider10% owner purchased ~$226K of NVCT shares in the open market
  5. Jun 20, 2025Insider10% owner purchased ~$45K of NVCT shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Nuvectis Pharma

OQRO holds no insider, Congress, fund or contract record for Nuvectis Pharma dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NVCT page.

Other recent filings by Mosseri Marlio Charles, 10% owner

The full history of Mosseri Marlio Charles, 10% owner is on the profile page.

How this filing works

Explore the data

Common questions

Which Nuvectis Pharma (NVCT) insider traded, and how much?

Mosseri Marlio Charles, 10% owner at Nuvectis Pharma, bought ~$88K of Nuvectis Pharma shares. 9,850 shares at $8.95, open market.

When did it happen, and when was it made public?

Traded: May 9, 2025. Filed: May 12, 2025. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean NVCT stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Nuvectis Pharma

Everything OQRO holds on this company is on its NVCT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data